Holy Stone Healthcare Co., Ltd   Report issue

For profit Phase 1 Phase 2
Founded: Taipei Taiwan (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2014
NCT02196662
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Holy Stone Healthcare Co., Ltd